Analystreport

Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at Citigroup Inc. from $800.00 to $750.00.

Bio-Rad Laboratories, Inc. Class A  (BIO) 
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm Check Earnings Report